Advertisement
Advertisement
Marolac

Marolac

ketorolac

Manufacturer:

ACME

Distributor:

D'Conner Pharma

Marketer:

Euro Generics
Concise Prescribing Info
Contents
Ketorolac trometamol
Indications/Uses
Short-term management of moderate to severe post-op pain.
Dosage/Direction for Use
Adult & childn >16 yr Initially 10 mg by IM or IV inj over at least 15 sec, then 10-30 mg every 4-6 hr as required (up to every 2 hr during initial post-op period). Max: 90 mg daily. Max duration of treatment: 2 days. Elderly & patient weighing <50 kg Max: 60 mg daily.
Contraindications
Hypersensitivity to ketorolac trometamol & other NSAIDs. History of PUD or GI bleeding, asthma. Suspected or confirmed cerebrovascular bleeding; hemorrhagic diatheses including coagulation disorders. Childn <16 yr.
Special Precautions
Carefully weigh potential risks & benefits of use on long-term basis. Monitor for signs of serious GI adverse events; monitor more closely if patient is on another NSAID. Not recommended during pregnancy, labour or delivery & in mothers who are breastfeeding.
Adverse Reactions
Nausea, dyspepsia, GI pain, dizziness, headache, sweating, dry mouth, bradycardia, purpura, thrombocytopenia, dyspnea, asthma, pruritus, urticaria, anaphylaxis, bronchospasm.
Drug Interactions
Concomitant use w/ MTX, diuretics, ACE inhibitors, warfarin, lithium, aminoglycosides & other NSAIDs.
MIMS Class
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
ATC Classification
M01AB15 - ketorolac ; Belongs to the class of acetic acid derivatives and related substances of non-steroidal antiinflammatory and antirheumatic products.
Presentation/Packing
Form
Marolac soln for inj 30 mg/mL
Packing/Price
1 mL x 1's
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement